SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001104659-24-024170
Filing Date
2024-02-14
Accepted
2024-02-14 19:36:52
Documents
1
Group Members
HENRY A. PLAIN, JR.JEAN M. GEORGELIGHTSTONE VENTURES II(A), L.P.LSV ASSOCIATES II, LLCMICHAEL A. CARUSI

Document Format Files

Seq Description Document Type Size
1 SC 13G/A tm246245d1_sc13ga.htm SC 13G/A 119863
  Complete submission text file 0001104659-24-024170.txt   121656
Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Subject) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-92616 | Film No.: 24641505
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116
Business Address 500 BOYLSTON STREET, SUITE 1380 BOSTON MA 02116 (617) 850 - 9700
Lightstone Ventures II, L.P. (Filed by) CIK: 0001699565 (see all company filings)

IRS No.: 820626297 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A